Wall Street effect on Asian stock exchanges, after the new record closing value filed yesterday by the Nasdaq Composite index, in the wake of the final approval of the FDA to the vaccine produced by Pfizer-BioNTech. The Tokyo Stock Exchange Nikkei 225 Index closed far from its intraday highs, gaining 0.87%. Very good Shanghai + 1.19%, Seoul + 1.40%, while the Sydney stock exchange is weak with + 0.22%. The Hong Kong stock exchange still stands today, with the Hang Seng close to + 2%.
Yesterday the United States Food and Drug Administration, the American government body that deals with the regulation of food and pharmaceutical products, definitively approved the first vaccine against Covid-19: that, precisely, of Pfizer- BioNTech which will now be marketed as Comirnaty, for the prevention of coronavirus in people aged 16 and over.
“While millions of people have already safely received Covid-19 vaccines, we recognize that for some, the approval of a vaccine by the FDA can now instill further confidence,” said FDA Commissioner Janet Woodcock. today’s milestone brings us closer to altering the course of this pandemic in the United States. ”
The vaccine was approved with Emergency Use Authorization (EUA) on 11 December 2020.
The news of the final okay gave wings to stocks interested in the New York Stock Exchange, instilling optimism in the equity markets.
In Asia, a wave of buy spilled in particular on the Hong Kong stock exchange, with the Hang Seng index climbing almost + 2% (now + 1.87% approx.): Purchases on the stocks of Chinese technology companies such as Tencent (+ 7%), Meituan, in flight by more than + 11% and Alibaba + 5%.
The Hang Seng Tech index gained 4.52%.
Yesterday the Nasdaq Composite jumped 1.55% to 14,942.65, testing a new record close. The S&P 500 rose 0.85% to 4,479.53 points, while the Dow Jones Industrial Average advanced 215.63 points to 35,335.71.